Equity Insider – Daily News Podcast Briefings

Equity Insider – Daily News Podcast Briefings
  • 5.0 (1)
  • NEWS
  • UPDATED DAILY

Equity Insider provides daily market news briefings and analysis, highlighting key developments across the global news and business sectors. Episodes are designed to keep listeners informed with timely, data-driven insights.

Episodes

  1. 22 JAN

    Protecting the Supply: North America’s Next Generation of Strategic Mineral Leaders

    https://markets-headlines.com/wp-content/uploads/2026/01/Protecting-the-Supply-North-Americas-Next-Generation-of-Strategic-Mineral-Leaders-1.mp4 The post Protecting the Supply: North America’s Next Generation of Strategic Mineral Leaders appeared first on markets-headlines.

    2 min

  2. 20 JAN

    Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating

    Issued on behalf of RUA GOLD Inc. VANCOUVER, BC, Jan. 20, 2026 — Equity Insider News Commentary – The global mining sector is undergoing a structural realignment as producer margins expand to record levels, with top-tier firms now reporting All-In Sustaining Costs (AISC) below $1,500 per ounce[1] while gold trades near historic $4,700 resistance. As […] The post Infrastructure Pivot Unlocks Margin Expansion: Operational Grit Triggers 2026 Asset Re-Rating appeared first on markets-headlines.

    2 min

  3. 16 JAN

    Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape

    Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Jan. 16, 2026 — Equity Insider News Commentary – The precision medicine sector is undergoing a structural realignment toward platform-based biologics, as the market prepares to surge from $138 billion this year to over $537 billion by 2035[1]. This shift marks the end of “one-size-fits-all” treatments, […] The post Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape appeared first on markets-headlines.

    2 min

  4. 14 JAN

    Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff

    Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Jan. 14, 2026 — Equity-Insider.com News Commentary – The precision oncology market is hitting a massive growth spurt, projected to rocket from $110 billion toward a staggering $225.65 billion by 2032[1]. This gold rush is accelerating as Big Pharma giants scramble to survive a looming $170 […] The post Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff appeared first on markets-headlines.

    2 min

  5. 12 JAN

    Sovereign Defense Boom: The €381 Billion Shift to Local Military Tech

    Issued on behalf of VisionWave Holdings, Inc. VANCOUVER, BC, Dec. 24, 2025– Equity Insider News Commentary – European and NATO allies confirmed a credible pathway to achieving 5% GDP defense spending by 2035 at the December 3 NATO Foreign Ministers meeting, reinforcing the strategic imperative for Allied nations to localize military production and reduce reliance […] The post Sovereign Defense Boom: The €381 Billion Shift to Local Military Tech appeared first on markets-headlines.

    1 min

  6. 11 JAN

    The New Arms Race: Investing in Speed, Agility, and Responsive Space Infrastructure

    Issued on behalf of Starfighters Space, Inc. Equity Insider News Commentary VANCOUVER, BC, Jan. 2, 2026 -Equity Insider- As global adversaries field operational hypersonic vehicles, the U.S. has reached a ‘Sputnik moment’ for tactical space access. With the Pentagon committing over $6.9 billion to hypersonic weapons development for FY 2025[1], the market is no longer […] The post The New Arms Race: Investing in Speed, Agility, and Responsive Space Infrastructure appeared first on markets-headlines.

    1 min

  7. 11 JAN

    Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize

    Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 2, 2026 – Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by 2032, powered by rising demand for curative treatments that target genetic diseases at their source[1]. The FDA approved three transformative cell therapies this December alone, marking an […] The post Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize appeared first on markets-headlines.

    3 min
  • 7 Episodes

About

Equity Insider provides daily market news briefings and analysis, highlighting key developments across the global news and business sectors. Episodes are designed to keep listeners informed with timely, data-driven insights.

Information